December 20, 2017 / 3:10 PM / a month ago

BRIEF-Shanghai Fosun Pharmaceutical Group's Unit Enters Capital Increase Agreement

Dec 20 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd:

* UNIT ENTERS CAPITAL INCREASE AGREEMENT WITH SHAREHOLDERS OF SHANGHAI HENLIUS, OTHER INVESTORS, SHANGHAI HENLIUS​

* FOSUN PHARMA INDUSTRIAL TO ACQUIRE 14.6 MILLION ADDITIONAL SHARES IN SHANGHAI HENLIUS AT RMB22.71 PER SHARE

* ‍OTHER INVESTORS TO BUY TOTAL OF 40.8 MILLION ADDITIONAL SHARES IN SHANGHAI HENLIUS AT RMB22.71/SHARE, FOR US$140 MILLION​

* SHANGHAI HENLIUS TO ISSUE 55.4 MILLION ADDITIONAL SHARES IN CO TO UNIT, OTHER INVESTORS FOR US$190 MILLION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below